http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0499778-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e29e759d65b7e915908ffc01c56b2c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9ba304908c7187b486482f16a0f6158
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
filingDate 1990-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2a2065d2276054b1c47185237eec75f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b3376d0ce1256f84ce7107d74a43239
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00dc6399b09933a2107411407da24882
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_377a66962451ab87a33c194c783c3d27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_389158d6dd94d52407bea706662560a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fea81c8ecfbe2bf7fcd7def9e2532323
publicationDate 1992-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0499778-A
titleOfInvention Ellagic sulfate derivative, production thereof and use thereof
abstract NEW MATERIAL:Compounds of formula I (R 1 -R 4 are lower alkoxy or sulfoxy, provided that at least two thereof are sulfoxy) and salts thereof. n EXAMPLE: Ellagic acid 3,3'4,4'-tetra(sulfate potassium salt). n USE: An aldose reductase inhibitor. n PREPARATION: An ellagic acid derivative of formula II (X 1 -X 4 are hydroxy or lower alkoxy) is sulfated, subsequently hydrolyzed and neutralized as necessary to obtain the objective compound of formula I. The reaction is carried out, e.g. by using chlorosulfonic acid preferably in the presence of a tertiary amine such as pyridine or N,N-dimethylaniline. An aldose reductase inhibitor containing the compound of formula I as the active component is suitable for preparation of a tablet, a capsule, an injection, etc., by the conventional method using a general carrier. n COPYRIGHT: (C)1992,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110128437-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110128437-B
priorityDate 1990-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24507
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281855
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID751
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24638
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407377111
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409928
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451597188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411161974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310

Total number of triples: 37.